FCCC LOGO Faculty Publications
Slingluff CL , Petroni GR , Molhoek KR , Brautigan DL , Chianese-Bullock KA , Shada AL , Smolkin ME , Olson WC , Gaucher A , Chase CM , Grosh WW , Weiss GR , Wagenseller AG , Olszanski AJ , Martin L , Shea SM , Erdag G , Ram P , Gershenwald JE , Weber MJ
Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)
Clinical Cancer Research. 2013 Jul;19(13) :3611-3620
PMID: WOS:000321095900028    PMCID: PMC 3700572   
Back to previous list
Abstract
Notes
Slingluff, Craig L., Jr. Petroni, Gina R. Molhoek, Kerrington R. Brautigan, David L. Chianese-Bullock, Kimberly A. Shada, Amber L. Smolkin, Mark E. Olson, Walter C. Gaucher, Alison Chase, Cheryl Murphy Grosh, William W. Weiss, Geoffrey R. Wagenseller, Aubrey G. Olszanski, Anthony J. Martin, Lainie Shea, Sofia M. Erdag, Gulsun Ram, Prahlad Gershenwald, Jeffrey E. Weber, Michael J.